Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-19-005357
Filing Date
2019-03-20
Accepted
2019-03-20 16:31:41
Documents
4
Period of Report
2019-05-22

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A dmtp20190317_pre14a.htm PRE 14A 1564808
2 a2.jpg GRAPHIC 212399
3 a1.jpg GRAPHIC 198666
4 dmtp20190317_pre14aimg001.gif GRAPHIC 4731
  Complete submission text file 0001437749-19-005357.txt   2138766
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36291 | Film No.: 19694961
SIC: 2834 Pharmaceutical Preparations